https://www.selleckchem.com/products/ff-10101.html
Anticoagulation use was not correlated with CHA DS -VASc score or cardioversion. Stroke and mortality were higher among patients not receiving anticoagulation, however, confirmation of this finding in larger randomized studies is warranted. Anticoagulation use is low after CABG and this practice does not appear to be affected by CHA DS VASc score or cardioversion. This differs with previously reported provider attitudes towards management of this condition. Stroke and mortality appear to be elevated for patients not receiving anticoagu